Search research articles
Contact Us
Filters
Showing results (41-50 of 126) with videos related to
Page
of 13
Sort By:
Journal of the American Academy of Dermatology
|
October 9, 2016
Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
Janny E Lommerts, Hansje-Eva Teulings, Khaled Ezzedine, et al.
The Journal of Dermatological Treatment
|
April 26, 2023
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study
Angela L Bosma, Louise A A Gerbens, Hajar El Khattabi, et al.
The Journal of Allergy and Clinical Immunology
|
October 6, 2014
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
Jochen Schmitt, Phyllis I Spuls, Kim S Thomas, et al.
The Journal of Investigative Dermatology
|
June 20, 2014
The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells
Marcel B M Teunissen, Nataliya G Yeremenko, Dominique L P Baeten, et al.
Therapeutic Drug Monitoring
|
May 21, 2019
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab
Eline De Keyser, Celine I Busard, Sven Lanssens, et al.
BMJ Open
|
August 31, 2018
Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
Aaron Mark Drucker, Alexandra Ellis, Zarif Jabbar-Lopez, et al.
Archives of Dermatology
|
June 24, 2004
Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine
Brent C Opmeer, Vera M R Heydendael, Corianne A J M De Borgie, et al.
The Journal of Dermatological Treatment
|
December 21, 2023
The wide variety of methotrexate dosing regimens for the treatment of atopic dermatitis: a systematic review
Anouk G M Caron, Manja Bloem, Hajar El Khattabi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 11, 2011
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men
Anja Blumeyer, Antonella Tosti, Andrew Messenger, et al.
Journal of the American Academy of Dermatology
|
March 6, 2021
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'"
Angela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 126) with videos related to
Sort By:
Page
of 13
Journal of the American Academy of Dermatology
|
October 9, 2016
Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
Janny E Lommerts, Hansje-Eva Teulings, Khaled Ezzedine, et al.
The Journal of Dermatological Treatment
|
April 26, 2023
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study
Angela L Bosma, Louise A A Gerbens, Hajar El Khattabi, et al.
The Journal of Allergy and Clinical Immunology
|
October 6, 2014
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
Jochen Schmitt, Phyllis I Spuls, Kim S Thomas, et al.
The Journal of Investigative Dermatology
|
June 20, 2014
The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells
Marcel B M Teunissen, Nataliya G Yeremenko, Dominique L P Baeten, et al.
Therapeutic Drug Monitoring
|
May 21, 2019
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab
Eline De Keyser, Celine I Busard, Sven Lanssens, et al.
BMJ Open
|
August 31, 2018
Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
Aaron Mark Drucker, Alexandra Ellis, Zarif Jabbar-Lopez, et al.
Archives of Dermatology
|
June 24, 2004
Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine
Brent C Opmeer, Vera M R Heydendael, Corianne A J M De Borgie, et al.
The Journal of Dermatological Treatment
|
December 21, 2023
The wide variety of methotrexate dosing regimens for the treatment of atopic dermatitis: a systematic review
Anouk G M Caron, Manja Bloem, Hajar El Khattabi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 11, 2011
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men
Anja Blumeyer, Antonella Tosti, Andrew Messenger, et al.
Journal of the American Academy of Dermatology
|
March 6, 2021
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'"
Angela L Bosma, Linde E M de Wijs, Michel H Hof, et al.
Page
of 13